Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices traded up today with the Dow Jones Industrial Average ( ^DJI) trading up 143 points (0.9%) at 16,970 as of Tuesday, July 1, 2014, 3:55 PM ET. The NYSE advances/declines ratio sits at 2,189 issues advancing vs. 849 declining with 140 unchanged. The Drugs industry as a whole closed the day up 1.2% versus the S&P 500, which was up 0.8%. Top gainers within the Drugs industry included Reliv' International ( RELV), up 2.5%, Natural Alternatives International ( NAII), up 2.6%, Merus Labs International ( MSLI), up 6.8%, Chembio Diagnostics ( CEMI), up 1.8% and Can Fite Biofarma ( CANF), up 2.6%. TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today: Chembio Diagnostics ( CEMI) is one of the companies that pushed the Drugs industry higher today. Chembio Diagnostics was up $0.06 (1.8%) to $3.49 on light volume. Throughout the day, 17,528 shares of Chembio Diagnostics exchanged hands as compared to its average daily volume of 24,300 shares. The stock ranged in a price between $3.46-$3.50 after having opened the day at $3.50 as compared to the previous trading day's close of $3.43. Chembio Diagnostics has a market cap of $32.9 million and is part of the health care sector. Shares are up 2.1% year-to-date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. Highlights from TheStreet Ratings analysis on CEMI go as follows: You can view the full analysis from the report here: Chembio Diagnostics Ratings Report STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.